DrugPatentWatch Database Preview
Glenmark Pharms Company Profile
What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?
GLENMARK PHARMS has eighty-eight approved drugs.
There are eight tentative approvals on GLENMARK PHARMS drugs.
Summary for Glenmark Pharms
| US Patents: | 0 |
| Tradenames: | 70 |
| Ingredients: | 66 |
| NDAs: | 88 |
Drugs and US Patents for Glenmark Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | EZETIMIBE AND SIMVASTATIN | ezetimibe; simvastatin | TABLET;ORAL | 208699-001 | Jun 27, 2019 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Glenmark Pharms | HAILEY 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 209297-001 | Jun 5, 2018 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Glenmark Pharms Ltd | COLESEVELAM HYDROCHLORIDE | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 202190-001 | Jul 16, 2018 | RX | No | No | See Pricing | See Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
